Absence of CMV viremia in high-grade glioma patients under low dosage glucocorticoid treatment

Neuro Oncol. 2017 Sep 1;19(9):1280-1282. doi: 10.1093/neuonc/nox065.

Authors

Martina Schneider¹, Eva-Maria Reitter¹, Marie-Theres Kastner¹, Jakob Thannesberger¹, Franz J J Rieder¹, Matthias Preusser¹, Christine Marosi¹, Christoph Steininger¹

Affiliation

¹ Department of Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Aged, 80 and over
Antibodies, Viral / immunology
Brain Neoplasms / drug therapy*
Brain Neoplasms / pathology
Cytomegalovirus / immunology
Cytomegalovirus Infections / epidemiology*
Cytomegalovirus Infections / etiology
Cytomegalovirus Infections / immunology
Dexamethasone / administration & dosage
Dexamethasone / adverse effects*
Female
Glioma / drug therapy*
Glucocorticoids / administration & dosage
Glucocorticoids / adverse effects*
Humans
Immunocompromised Host
Immunoglobulin G / immunology
Male
Middle Aged
Neoplasm Grading
Viremia / epidemiology*
Viremia / etiology
Viremia / immunology

Substances

Antibodies, Viral
Glucocorticoids
Immunoglobulin G
Dexamethasone